Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA grants satraplatin fast track designation

Sep. 25, 2003

Corixa initiates phase I clinical study for NSCLC vaccine

Sep. 23, 2003

Ligand completes enrollment in pivotal study of Targretin in NSCLC

Sep. 23, 2003

Brand name chosen for ABI-007

Sep. 23, 2003

Six-month priority review granted for Eloxatin sNDA

Sep. 22, 2003

Dow and Sunol collaborate on plant-based production of antibody for cancer

Sep. 22, 2003

Fast track designation awarded to Advexin for head & neck cancer

Sep. 22, 2003

Canadian scientists design new photosensitizers for cancer, ocular disorders, etc.

Sep. 19, 2003

Novel antitumor protein kinase inhibitors in early development at Vertex

Sep. 19, 2003

AstraZeneca claims novel KDR inhibitors for cancer and other disorders

Sep. 19, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...